Safety and efficacy of empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK)

被引：0
|
作者：
Aamir, A. H. [1 ]
Raja, U. Y. [2 ]
Asghar, A. [3 ]
Mahar, S. A. [4 ]
Ghaffar, T. [5 ]
Ahmed, I. [6 ]
Qureshi, F. M. [7 ]
Zafar, J. [8 ]
Hasan, M. I. [8 ]
Riaz, A. [9 ]
Raza, S. A. [10 ]
Khosa, I. A. [11 ]
Khan, J. [12 ]
Raza, M. [13 ]
Bagar, J. B. [14 ]
机构：
[1] Hayatabad Med Complex, Dept Diabet Endocrinol & Metab Dis, Peshawar, Pakistan
[2] Shifa Int Hosp, Dept Endocrinol, Islamabad, Pakistan
[3] Fatimiyah Hosp, Dept Endocrinol, Karachi, Pakistan
[4] Natl Inst Cardiovasc Dis, Dept Endocrinol, Karachi, Pakistan
[5] Hayatabad Med Complex, Dept Endocrinol, Peshawar, Pakistan
[6] Lady Reading Hosp, Dept Endocrinol, Peshawar, Pakistan
[7] Al Khaliq Hosp, Dept Endocrinol, Lahore, Pakistan
[8] Hanif Med Ctr, Dept Endocrinol, Islamabad, Pakistan
[9] Jinnah Hosp, Lahore, Pakistan
[10] Natl Def Ctr, Lahore, Pakistan
[11] Balochistan Med Ctr, Quetta, Pakistan
[12] Kings Coll London, London, England
[13] Shaheed Zulfikar Ali Bhutto Inst Sci & Technol, Karachi, Pakistan
[14] Univ Karachi, Karachi, Pakistan
来源：
DIABETIC MEDICINE | 2021年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A24 (P187)
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial
    Azizul Hasan Aamir
    Umar Yousaf Raja
    Faisal Masood Qureshi
    Ali Asghar
    Saeed Ahmed Mahar
    Ibrar Ahmed
    Tahir Ghaffar
    Jamal Zafar
    Mohammad Imtiaz Hasan
    Amna Riaz
    Syed Abbas Raza
    Irshad Ahmed Khosa
    Jahanzeb Khan
    Jaffer Bin Baqar
    [J]. BMC Endocrine Disorders, 22
  • [2] Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial
    Aamir, Azizul Hasan
    Raja, Umar Yousaf
    Qureshi, Faisal Masood
    Asghar, Ali
    Mahar, Saeed Ahmed
    Ahmed, Ibrar
    Ghaffar, Tahir
    Zafar, Jamal
    Hasan, Mohammad Imtiaz
    Riaz, Amna
    Raza, Syed Abbas
    Khosa, Irshad Ahmed
    Khan, Jahanzeb
    Bin Baqar, Jaffer
    [J]. BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [3] Comparison of empagliflozin and vildagliptin for efficacy and safety in type 2 diabetes mellitus in the Pakistani population
    Khan, Asima
    Khan, Izhan A.
    Abidi, Hussain
    Ahmed, Mansoor
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [4] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes
    Kohler, Sven
    Salsali, Afshin
    Hantel, Stefan
    Kaspers, Stefan
    Woerle, Hans J.
    Kim, Gabriel
    Broedl, Uli C.
    [J]. CLINICAL THERAPEUTICS, 2016, 38 (06) : 1299 - 1313
  • [5] Safety and tolerability of empagliflozin in patients with Type 2 diabetes
    Salsali, A.
    Kohler, S.
    Hantel, S.
    Kim, G.
    Woerle, H. J.
    Broedl, U. C.
    [J]. DIABETIC MEDICINE, 2016, 33 : 66 - 66
  • [6] THE EFFICACY AND RENAL SAFETY OF SWITCHING FROM DAPAGLIFLOZIN TO EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1374 - 1374
  • [7] Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
    Varshney, Amit
    Rawat, Ramakant
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (08):
  • [8] Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
    Kyle T. Baron
    Sreeraj Macha
    Uli C. Broedl
    Valerie Nock
    Silke Retlich
    Matthew Riggs
    [J]. Diabetes Therapy, 2016, 7 : 455 - 471
  • [9] The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan
    Rohban, T
    Khadija, B
    Maamoun, M
    Khaled, O
    Hisham, E
    Moghazy, M
    Raefat, R
    Salah, S
    Assem, Z
    Mohammed, A
    Nidal, E
    Ramzi, E
    Jihad, H
    Oussama, M
    Hassan, S
    Asman, M
    Ida, AK
    Khalid, A
    Mustaffa, E
    Bebakar, W
    Mohamad, KW
    Nazih, A
    Akram, E
    Camille, E
    Sami, F
    Fadl, F
    Ahmad, G
    Said, H
    Yahya, J
    Karim, KA
    Marwan, K
    Mamdouh, M
    Haitham, R
    Dolly, MV
    Ali, M
    Hicham, N
    Issam, Y
    [J]. DIABETES CARE, 2005, 28 (02) : 421 - 422
  • [10] Efficacy and Safety of Empagliflozin in Type 1 Diabetes Mellitus Patients: A Systematic Review
    Saha, Sumanta
    Saha, Sujata
    [J]. TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 25 (04) : 426 - 438
12345